Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance
Authors
Keywords
-
Journal
Molecular Oncology
Volume 9, Issue 6, Pages 1169-1185
Publisher
Wiley
Online
2015-02-25
DOI
10.1016/j.molonc.2015.02.008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CES2, ABCG2, TS and Topo-I Primary and Synchronous Metastasis Expression and Clinical Outcome in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Regimen
- (2014) Nicola Silvestris et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis
- (2013) C. C. J. M. Simons et al. ANNALS OF ONCOLOGY
- Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
- (2013) Vlad Popovici et al. BMC CANCER
- Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer
- (2013) Dimitra K. Alexopoulou et al. CLINICAL BIOCHEMISTRY
- Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status
- (2013) AMÉLIE PETITPREZ et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
- (2013) Eva Budinska et al. JOURNAL OF PATHOLOGY
- High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer
- (2013) Mads H. Rasmussen et al. Molecular Oncology
- A colorectal cancer classification system that associates cellular phenotype and responses to therapy
- (2013) Anguraj Sadanandam et al. NATURE MEDICINE
- Keratin23 (KRT23) Knockdown Decreases Proliferation and Affects the DNA Damage Response of Colon Cancer Cells
- (2013) Karin Birkenkamp-Demtröder et al. PLoS One
- Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior
- (2012) Beatriz Perez Villamil et al. BMC CANCER
- MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
- (2012) Sidong Huang et al. CELL
- Identification of a Poor-PrognosisBRAF-Mutant–Like Population of Patients With Colon Cancer
- (2012) Vlad Popovici et al. JOURNAL OF CLINICAL ONCOLOGY
- Overexpression of Snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells
- (2012) Fan Fan et al. Cancer Medicine
- TRP Channels and Cancer: New Targets for Diagnosis and Chemotherapy
- (2012) Giorgio Santoni et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS
- (2011) Robert W. Robey et al. Anti-Cancer Agents in Medicinal Chemistry
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Inhibitors of Aldo-Keto Reductases AKR1C1-AKR1C4
- (2011) P. Brozic et al. CURRENT MEDICINAL CHEMISTRY
- SNAIL Regulates Interleukin-8 Expression, Stem Cell–Like Activity, and Tumorigenicity of Human Colorectal Carcinoma Cells
- (2011) Wei–Lun Hwang et al. GASTROENTEROLOGY
- The Emergence of Drug Transporter-Mediated Multidrug Resistance to Cancer Chemotherapy
- (2011) Chung-Pu Wu et al. MOLECULAR PHARMACEUTICS
- Epigenetics and colorectal cancer
- (2011) Victoria Valinluck Lao et al. Nature Reviews Gastroenterology & Hepatology
- Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer
- (2011) Niels Frank Jensen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group
- (2011) Linlin Zhong et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Metastatic Colorectal Cancer: From Improved Survival to Potential Cure
- (2010) David J. Gallagher et al. ONCOLOGY
- A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX30 and chronomodulated XELOX30 as first-line therapy in patients with advanced colorectal cancer
- (2009) C. Qvortrup et al. ANNALS OF ONCOLOGY
- Steroid Hormone Transforming Aldo-Keto Reductases and Cancer
- (2009) Trevor M. Penning et al. Annals of the New York Academy of Sciences
- Epithelial–mesenchymal transition with expression of SNAI1-induced chemoresistance in colorectal cancer
- (2009) Hiromitsu Hoshino et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
- (2009) Yves Pommier CHEMICAL REVIEWS
- A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?
- (2009) Miriam Koopman et al. EUROPEAN JOURNAL OF CANCER
- Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
- (2009) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity
- (2009) T. D. Pfister et al. MOLECULAR CANCER THERAPEUTICS
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance
- (2009) Zachary W. Veitch et al. Pharmacogenetics and Genomics
- Genetic polymorphisms inGSTgenes and survival of colorectal cancer patients treated with chemotherapy
- (2009) Silvia Funke et al. PHARMACOGENOMICS
- Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer
- (2008) L. L. Scurr et al. CLINICAL CANCER RESEARCH
- Resistance mechanisms to cancer chemotherapy
- (2008) Kelly Marie Redmond Frontiers in Bioscience-Landmark
- Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial
- (2008) Michael S. Braun et al. JOURNAL OF CLINICAL ONCOLOGY
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
- Topoisomerase levels determine chemotherapy responsein vitroandin vivo
- (2008) Darren J. Burgess et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inactivation of the anticancer drugs doxorubicin and oracin by aldo–keto reductase (AKR) 1C3
- (2008) Romana Novotna et al. TOXICOLOGY LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started